Kepivance
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Kepivance, covering 2008-02-08 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Phase 1, Phase 2]